- Home
- VWAV vs ANEB Comparison
VWAV vs ANEB Comparison
Compare VWAV & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VWAV
- ANEB
- Stock Information
- Founded
- VWAV 2024
- ANEB 2020
- Country
- VWAV United States
- ANEB United States
- Employees
- VWAV N/A
- ANEB N/A
- Industry
- VWAV Computer Software: Prepackaged Software
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- VWAV Technology
- ANEB Health Care
- Exchange
- VWAV Nasdaq
- ANEB Nasdaq
- Market Cap
- VWAV 41.4M
- ANEB 39.0M
- IPO Year
- VWAV N/A
- ANEB 2021
- Fundamental
- Price
- VWAV $2.35
- ANEB $3.19
- Analyst Decision
- VWAV
- ANEB Buy
- Analyst Count
- VWAV 0
- ANEB 2
- Target Price
- VWAV N/A
- ANEB $8.00
- AVG Volume (30 Days)
- VWAV 483.1K
- ANEB 1.1M
- Earning Date
- VWAV 01-01-0001
- ANEB 05-13-2025
- Dividend Yield
- VWAV N/A
- ANEB N/A
- EPS Growth
- VWAV N/A
- ANEB N/A
- EPS
- VWAV N/A
- ANEB N/A
- Revenue
- VWAV N/A
- ANEB N/A
- Revenue This Year
- VWAV N/A
- ANEB N/A
- Revenue Next Year
- VWAV N/A
- ANEB N/A
- P/E Ratio
- VWAV N/A
- ANEB N/A
- Revenue Growth
- VWAV N/A
- ANEB N/A
- 52 Week Low
- VWAV $2.06
- ANEB $0.80
- 52 Week High
- VWAV $3.86
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- VWAV N/A
- ANEB 82.91
- Support Level
- VWAV N/A
- ANEB $1.53
- Resistance Level
- VWAV N/A
- ANEB $3.42
- Average True Range (ATR)
- VWAV 0.00
- ANEB 0.18
- MACD
- VWAV 0.00
- ANEB 0.17
- Stochastic Oscillator
- VWAV 0.00
- ANEB 87.83
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.